- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/74 - Major histocompatibility complex [MHC]
Patent holdings for IPC class C07K 14/74
Total number of patents in this class: 1859
10-year publication summary
|
94
|
105
|
124
|
188
|
250
|
246
|
295
|
249
|
203
|
31
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1179 |
525 |
| Cue Biopharma, Inc. | 175 |
88 |
| CRISPR Therapeutics AG | 371 |
54 |
| Regeneron Pharmaceuticals, Inc. | 4078 |
53 |
| University Health Network | 1022 |
37 |
| 10X Genomics, Inc. | 1111 |
22 |
| Board of Regents, The University of Texas System | 5671 |
18 |
| The Regents of the University of California | 19630 |
16 |
| Imcyse SA | 74 |
15 |
| Oregon Health & Science University | 759 |
15 |
| Sangamo Therapeutics, Inc. | 428 |
15 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1518 |
14 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 312 |
13 |
| Gritstone bio, Inc. | 114 |
13 |
| Universite de Montreal | 345 |
12 |
| Xyphos Biosciences Inc. | 34 |
12 |
| Sana Biotechnology, Inc. | 137 |
12 |
| Immunocore Limited | 205 |
11 |
| UTi Limited Partnership | 439 |
11 |
| Albert Einstein College of Medicine, Inc. | 570 |
10 |
| Other owners | 893 |